Together to mitigate the impacts of Covid-19

Company

In view of the Coronavirus pandemic, Eurogentec has established and implemented measures to ensure the health and safety of its employees, partners and customers, but also to pursue our mission of providing high quality products.

Seraing, Belgium, March 25th 2020 .  

Dear customers and partners,

The unprecedented crisis that we are experiencing is disrupting daily lives everywhere, but we are ready to help. In view of the Coronavirus (Covid-19) pandemic, we would like you to know that Eurogentec has established and implemented measures to ensure the health and safety of its employees, partners and customers, but also to pursue our mission of providing high quality products.

Together we can help mitigate the impact of the pandemic. 

Recently, we received official confirmation that our activities were recognized as critical and essential in the current crisis. Through several of our products and services, Eurogentec is closely involved in the scientific and medical efforts put in place to address this crisis.  

As such, we are doing our utmost to meet the demands for oligos and qPCR related products. Indeed, both hospitals and diagnostic companies are currently using our primers and probes as well as our qPCR mixes for use in their virus detection tests.  

Thanks to our biomanufacturing unit, it is highly likely that we will soon be involved in the development and production of vaccines against CoV-2-SARS and other types of health scourges. The management of Kaneka Eurogentec is particularly proud, together with its staff, of contributing to any solution to this unprecedented pandemic and hence of being socially responsible.  

With this in mind, we will continue our activities but in a reduced manner and under strict conditions. The measures of physical distancing between people and flexible work hours have been strengthened.

Nothing changes for you, and we remain at your disposal. 

We have organised teleworking for all of our employees where possible. All of Eurogentec's activities are maintained and all team members remain reachable and at your disposal by telephone, e-mail and video conference.  

We offer our support and well wishes during these times of uncertainty. Take good care of yourself and your loved ones.

Trending Now

Kaneka Eurogentec completes commercial mRNA GMP facility expansion

Previous post

Discovery of our facilities by Minister Willy Borsus and AWEX members

Next post

Recommended for you

Kaneka Eurogentec completes commercial mRNA..

Company

Newly accredited GMP facility for commercial manufacturing of mRNA in anticipation of customer BLA submission....
Continue Reading
24-25 March 2026

Nextgen Biomed

London, UK

Meet Eurogentec at "Nextgen Biomed"

@ London, UK
📅March 24-25, 2026
📍London (UK) - Booth #61
...
Continue Reading
17-20 November 2025

Medica

Düsseldorf, DE

Meet our team at "Medica"

@ Düsseldorf, DE
📅 November 17-20, 2025
📍Dusseldorf (DE) - AWEX Belgian Pavilion (Hall 15)
...
Continue Reading